SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-013580
Filing Date
2023-05-10
Accepted
2023-05-10 16:05:59
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20230331_10q.htm   iXBRL 10-Q 585419
2 EXHIBIT 31.1 ex_511786.htm EX-31.1 11313
3 EXHIBIT 31.2 ex_511787.htm EX-31.2 11509
4 EXHIBIT 32.1 ex_511788.htm EX-32.1 4406
5 EXHIBIT 32.2 ex_511789.htm EX-32.2 4612
  Complete submission text file 0001437749-23-013580.txt   3593468

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20230331.xsd EX-101.SCH 41426
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20230331_def.xml EX-101.DEF 262620
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20230331_lab.xml EX-101.LAB 225430
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20230331_pre.xml EX-101.PRE 286141
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20230331_cal.xml EX-101.CAL 29287
54 EXTRACTED XBRL INSTANCE DOCUMENT bcda20230331_10q_htm.xml XML 464068
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 23906309
SIC: 2836 Biological Products, (No Diagnostic Substances)